NEWS
Advancements in Patient-Centered Care
Stay up to date with the latest advancements in oral oncolytics, medically-integrated oncology, and cancer care best practices.
Larotrectinib (Vitrakvi®) Overview
February 12, 2021
NCODA Welcomes Collaboration with Evofem Biosciences to Educate Oncology Community about Phexxi® – A Non-Hormonal Birth Control Option for Women with Cancer
February 10, 2021
NCODA Welcomes Five New Executive Council Members
February 8, 2021
Evofem Biosciences and NCODA Announce Collaboration to Educate Oncology Community about Phexxi®, A Non-Hormonal Birth Control Option for Women with Cancer
February 4, 2021
Exelixis announces FDA approval for CABOMETYX(R) (cabozantinib) with OPDIVO(R) (nivolumab)
January 27, 2021
New Indication for ENHERTU® (fam-trastuzumab deruxtecan-nxki)
January 20, 2021
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis
January 19, 2021
Most Favored Nation: Temporary Restraining Order Issued
December 23, 2020
MOST FAVORED NATION MODEL: NOT THE ANSWER FOR PATIENTS
December 21, 2020
Tazemetostat (Tazverik®) Management in Relapsed/Refractory Follicular Lymphoma
December 18, 2020
SUPREME COURT RULES UNANIMOUS: REGULATES PHARMACY BENEFIT MANAGERS
December 11, 2020
Intermountain Healthcare
November 19, 2020
RESOURCES
Cost Avoidance Waste Tracker
PQI in Action
OCE Sheets
IVE Sheets
Treatment Support Kits
PQI Podcast
Members
Member Resources
OPTA
Committees
Member Login
Events
Webinars
Spring Forum
Oncology Institute
PSO Annual Meeting
Fall Summit
315-655-4640
P.O. Box 468
Cazenovia, NY 13035
NURSE RESOURCES
Through collaboration between oncology nurses throughout North America, these resources are available to all NCODA members.